Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N.

Vaccine. 2019 Feb 28;37(10):1374-1376. doi: 10.1016/j.vaccine.2019.01.038. Epub 2019 Feb 4. No abstract available.

2.

A report on the status of vaccination in Europe.

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N.

Vaccine. 2018 Aug 9;36(33):4979-4992. doi: 10.1016/j.vaccine.2018.06.044. Epub 2018 Jul 4. Review. Erratum in: Vaccine. 2019 Feb 28;37(10):1374-1376.

3.

Protective effects of Vitex doniana (Black plum) against ischemic testes torsion injury: Histological and morphometric features.

Adelodun ST, Adewole OS, Bejide RA, Adeyemi DO, Arayombo BE, Saka OS, Olayode AA.

Pathophysiology. 2016 Sep;23(3):157-68. doi: 10.1016/j.pathophys.2016.05.002. Epub 2016 May 25.

PMID:
27342759
4.

Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells.

Küçüktürkmen B, Devrim B, Saka OM, Yilmaz Ş, Arsoy T, Bozkir A.

Drug Dev Ind Pharm. 2017 Jan;43(1):12-21. doi: 10.1080/03639045.2016.1200069. Epub 2016 Jun 29.

PMID:
27277750
5.

Lipoid proteinosis.

Kartal D, Çınar SL, Kartal L, Saka ÖŞ, Borlu M.

Acta Dermatovenerol Alp Pannonica Adriat. 2016;25(1):19-21.

6.

Assessment of the Turkish Version of the King's Stool Chart for Evaluating Stool Output and Diarrhea Among Patients Receiving Enteral Nutrition.

Sucu Dag G, Dicle A, Saka O, Whelan K.

Gastroenterol Nurs. 2015 May-Jun;38(3):218-25. doi: 10.1097/SGA.0000000000000114.

PMID:
25946479
7.

Comparison of predictor approaches for longitudinal binary outcomes: application to anesthesiology data.

Aktas Samur A, Coskunfirat N, Saka O.

PeerJ. 2014 Oct 30;2:e648. doi: 10.7717/peerj.648. eCollection 2014.

8.

How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

Höhne JM, Demarteau N, Saka Ö, Standaert B, Kleintjens J.

Value Health. 2014 Nov;17(7):A675-6. doi: 10.1016/j.jval.2014.08.2509. Epub 2014 Oct 26. No abstract available.

9.

National Immunisation Technical Advisory Groups - A Framework For Assessment and Insights From Research.

Kleintjens J, King S, Hernández-Pastor LJ, Abels M, Saka Ö, Bichon J.

Value Health. 2014 Nov;17(7):A449-50. doi: 10.1016/j.jval.2014.08.1209. Epub 2014 Oct 26. No abstract available.

10.

MIE2014 preface.

Lovis C, Séroussi B, Hasman A, Pape-Haugaard L, Saka O, Andersen SK.

Stud Health Technol Inform. 2014;205:v-vi. No abstract available.

PMID:
25160463
11.

Preparation and in vitro/in vivo evaluation of mucosal adjuvant in situ forming gels with diphtheria toxoid.

Ozbılgın ND, Saka OM, Bozkır A.

Drug Deliv. 2014 Mar;21(2):140-7. doi: 10.3109/10717544.2013.834754.

PMID:
24559517
12.

A systematic review and meta-analysis of acute stroke unit care: what's beyond the statistical significance?

Sun Y, Paulus D, Eyssen M, Maervoet J, Saka O.

BMC Med Res Methodol. 2013 Oct 28;13:132. doi: 10.1186/1471-2288-13-132. Review.

13.

Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in atrial fibrillation in the Belgian healthcare setting.

Kleintjens J, Li X, Simoens S, Thijs V, Goethals M, Rietzschel ER, Asukai Y, Saka Ö, Evers T, Faes P, Vansieleghem S, De Ruyck M.

Pharmacoeconomics. 2013 Oct;31(10):909-18. doi: 10.1007/s40273-013-0087-9.

14.

Ischemia modified albumin levels cannot predict stress induced ischemia shown by myocardial perfusion scintigraphy.

Koc ZP, Erkilic M, Basarıcı I, Deger N, Ozdem S, Saka O.

Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):202-6. doi: 10.1016/j.remn.2012.02.002. Epub 2012 May 6.

PMID:
22980127
15.

Participating or not in a cardiac rehabilitation programme: factors influencing a patient's decision.

De Vos C, Li X, Van Vlaenderen I, Saka O, Dendale P, Eyssen M, Paulus D.

Eur J Prev Cardiol. 2013 Apr;20(2):341-8. doi: 10.1177/2047487312437057. Epub 2012 Jan 20.

PMID:
22345682
16.

Risk prediction using a neonatal therapeutic intervention scoring system in VLBW and ELBW preterm infants.

Oygur N, Ongun H, Saka O.

Pediatr Int. 2012 Aug;54(4):496-500. doi: 10.1111/j.1442-200X.2012.03576.x. Epub 2012 Apr 18.

PMID:
22320841
17.

Formulation and in vitro characterization of PEGylated chitosan and polyethylene imine polymers with thrombospondin-I gene bearing pDNA.

Saka OM, Bozkir A.

J Biomed Mater Res B Appl Biomater. 2012 May;100(4):984-92. doi: 10.1002/jbm.b.32661. Epub 2012 Jan 25.

PMID:
22279036
18.

Ethnic differences in blood pressure monitoring and control in south east London.

Schofield P, Saka O, Ashworth M.

Br J Gen Pract. 2011 Apr;61(585):190-6. doi: 10.3399/bjgp11X567126.

19.

Usability of a web-based personal nutrition management tool.

Bozkurt S, Zayim N, Gulkesen KH, Samur MK, Karaağaoglu N, Saka O.

Inform Health Soc Care. 2011 Dec;36(4):190-205. doi: 10.3109/17538157.2011.553296. Epub 2011 Feb 23.

PMID:
21345010
20.

Comparison of methods for prediction of prostate cancer in Turkish men with PSA levels of 0-10 ng/mL.

Gulkesen KH, Koksal IT, Bilge U, Saka O.

J BUON. 2010 Jul-Sep;15(3):537-42.

21.

Informal social networks amongst administrative staff at a university hospital.

Bilge U, Senol U, Saka O.

Stud Health Technol Inform. 2009;150:282-6.

PMID:
19745314
22.

Cost of stroke in the United Kingdom.

Saka O, McGuire A, Wolfe C.

Age Ageing. 2009 Jan;38(1):27-32. doi: 10.1093/ageing/afn281.

PMID:
19141506
23.

Cost-effectiveness of stroke unit care followed by early supported discharge.

Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CC.

Stroke. 2009 Jan;40(1):24-9. doi: 10.1161/STROKEAHA.108.518043. Epub 2008 Nov 13.

PMID:
19008473
24.

Radicular peroxide penetration from carbamide peroxide gels during intracoronal bleaching.

Gökay O, Ziraman F, Cali Asal A, Saka OM.

Int Endod J. 2008 Jul;41(7):556-60. doi: 10.1111/j.1365-2591.2008.01384.x. Epub 2008 Mar 18.

PMID:
18355252
25.

Agent based simulations in healthcare.

Bilge U, Saka O.

Stud Health Technol Inform. 2006;124:699-704.

PMID:
17108597
26.

Prevalence and risk factors of obesity in school children in Antalya, Turkey.

Turkkahraman D, Bircan I, Tosun O, Saka O.

Saudi Med J. 2006 Jul;27(7):1028-33.

PMID:
16830025
27.

Instructional technology adoption of medical faculty in teaching.

Zayim N, Yıldırım S, Saka O.

Stud Health Technol Inform. 2005;116:255-60.

PMID:
16160268
28.

Formulation and investigation of 5-FU nanoparticles with factorial design-based studies.

Bozkir A, Saka OM.

Farmaco. 2005 Oct;60(10):840-6. Epub 2005 Aug 8.

PMID:
16087183
29.
31.

Endoscopic transnasal dacryocystorhinostomy and bicanalicular silicone tube intubation.

Apaydin KC, Fisenk F, Karayalcin B, Akar Y, Saka O.

Ophthalmologica. 2004 Sep-Oct;218(5):306-11.

PMID:
15334010
33.

The effect of duodenogastric reflux on Helicobacter pylori presence and gastric histopathologic changes.

Taşkin V, Sedele M, Saka O, Kantarçeken B.

Turk J Gastroenterol. 2003 Dec;14(4):239-42.

34.

The significance of autoantibodies in non-Hodgkin's lymphoma.

Timurağaoğlu A, Duman A, Ongüt G, Saka O, Karadoğan I.

Leuk Lymphoma. 2000 Dec;40(1-2):119-22.

PMID:
11426612
35.

Serum prolactin levels in Behçet's disease.

Apaydin KC, Duranoglu Y, Ozgürel Y, Saka O.

Jpn J Ophthalmol. 2000 Jul-Aug;44(4):442-5.

PMID:
10974304
36.

Clarifications and relationships between estrogen and prostaglandins.

Taskin O, Trak B, Mendilcioglu I, Saka O.

Fertil Steril. 2000 Apr;73(4):873-4. No abstract available.

PMID:
10787293
37.

Value of morphometry in distinguishing atypical reactive mesothelial and adenocarcinoma cells in pleural effusions.

Elpek GO, Paksoy N, Saka O.

Diagn Cytopathol. 1999 Aug;21(2):148-50. No abstract available.

PMID:
10425055
39.

Ocular and visual side effects of systemic cyclosporine.

Apaydin C, Gur B, Yakupoglu G, Saka O.

Ann Ophthalmol. 1992 Dec;24(12):465-9.

PMID:
1485743
40.

Fertility survey in semi-urban.

Rengin E, Saka O.

Acta Reprod Turc. 1986;7(3-4):53-65.

PMID:
12280958
41.

[Experimental thyroiditis in guinea pigs].

Saka O.

Tip Fak Mecm. 1966;29(2):224-7. Turkish. No abstract available.

PMID:
5965216
42.

The effect of fluoride on the thyroid of the rat.

Saka O, Hallaç P, Urgancioğlu I.

New Istanbul Contrib Clin Sci. 1965;8(2):87-90. No abstract available.

PMID:
5832584
43.

[A factor, present in insulin, which produces hyperglycemia and glycogenolysis].

SAKA O.

Sem Hop. 1951 Dec 2;27(89):3576-9. Undetermined Language. No abstract available.

PMID:
14913238
44.

[Hyperglycemic-glycogenolytic factor of the pancreas].

SAKA O.

Tip Fak Mecm. 1951;14(4):581-8. Undetermined Language. No abstract available.

PMID:
14942853
45.

[Variations in carbohydrate metabolism in alloxan diabetes in the rabbit and glycogen nephrosis of the renal tubular epithelium].

SAKA O, PAR EI.

Tip Fak Mecm. 1951;14(2):277-83. Undetermined Language. No abstract available.

PMID:
14942829

Supplemental Content

Support Center